Our results demonstrated that DLC1 cooperates with PLCD1 to inhibit migration, and the colorectal cancer-associated DLC1 START mutants that displayed reduced binding to PLCD1 had impaired DLC1 tumor suppressor functions, suggesting the interaction with PLCD1 is essential for the full tumor suppressor function of DLC1. This evidence concerns the gene DLC1 and colorectal cancer.